• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Trending
Hamburger Menu Hamburger Menu
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Brought to you by:

Cell & Gene Therapy

Explore the latest news and insight around cell and gene therapy, including new technology and information on treatments in this growing field. See how pharma is leveraging gene therapy and cell therapy to prevent and treat disease.

Brought to you by:
0
ocean covering up money lost investment
Biotech

Novo ends all cell therapy R&D, lets go of staff

Novo is looking for partners to further develop its cell therapy programs, a spokesperson told Fierce Biotech.
Gabrielle Masson Oct 10, 2025 3:30pm
transparent open honest clean wipe squeegee clear

Cabaletta’s CAR-T wipes out B cells with no preconditioning

Oct 10, 2025 11:11am
circle

BMS inks $1.5B deal to pull Orbital into its sphere of influence

Oct 10, 2025 8:45am
Closeup of blue eye on black background

AviadoBio secures option to rare eye disease gene therapy

Oct 9, 2025 8:50am
bet poker chips

ARPA-H goes all in on in vivo cell therapy

Oct 8, 2025 4:04pm
Tiny green sprout growing from soil

Chiesi fertilizes Arbor's gene therapy with $2B biobucks deal

Oct 6, 2025 7:00am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2025 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings